Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Harmony Biosciences (HRMY) Tops Q2 EPS by 15c
August 1, 2023 7:34 AM EDTHarmony Biosciences (NASDAQ: HRMY) reported Q2 EPS of $0.76, $0.15 better than the analyst estimate of $0.61. Revenue for the quarter came in at $134.2 million versus the consensus estimate of $142.02 million.
For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.
... More


